TY  - GEN
AU  - Magvanjav,Oyunbileg
AU  - Gong,Yan
AU  - McDonough,Caitrin W
AU  - Chapman,Arlene B
AU  - Turner,Stephen T
AU  - Gums,John G
AU  - Bailey,Kent R
AU  - Boerwinkle,Eric
AU  - Beitelshees,Amber L
AU  - Tanaka,Toshihiro
AU  - Kubo,Michiaki
AU  - Pepine,Carl J
AU  - Cooper-DeHoff,Rhonda M
AU  - Johnson,Julie A
TI  - Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials
SN  - 2047-9980
PY  - 2018///0702
KW  - Adolescent
KW  - Adrenergic beta-Antagonists
KW  - adverse effects
KW  - Adult
KW  - Aged
KW  - Aldehyde Dehydrogenase 1 Family
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - therapeutic use
KW  - Antihypertensive Agents
KW  - Atenolol
KW  - Blood Pressure
KW  - drug effects
KW  - Calcium Channel Blockers
KW  - Chi-Square Distribution
KW  - Drug Combinations
KW  - Drug Resistance
KW  - genetics
KW  - Female
KW  - Florida
KW  - Genome-Wide Association Study
KW  - Georgia
KW  - Humans
KW  - Hydrochlorothiazide
KW  - Hypertension
KW  - diagnosis
KW  - Indoles
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Odds Ratio
KW  - Pharmacogenetics
KW  - Pharmacogenomic Variants
KW  - Polymorphism, Single Nucleotide
KW  - Prospective Studies
KW  - Retinal Dehydrogenase
KW  - Risk Factors
KW  - Sodium Chloride Symporter Inhibitors
KW  - Treatment Outcome
KW  - Vasodilator Agents
KW  - Verapamil
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1161/JAHA.117.006522
ER  -